GlassScriptPhysician profile
Andrew Martin Smith
NPI 1114301397
$5,071.66
in general payments reported to CMS, 2019-2025
26 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $24.88 · 2021: $1,412 · 2022: $949 · 2023: $382 · 2024: $1,599 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.10 |
| Travel and Lodging | $824.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,393.14 | 2019-2024 | Everest Spinal System, Cascadia Interbody System, Capri Corpectomy Cage System |
| Si-Bone, INC. | $1,289.04 | 2022-2025 | |
| Medical Device Business Services, INC. | $896.66 | 2022 | |
| Alphatec Spine, INC | $158.41 | 2024 | |
| Alon Medical Technology | $151.29 | 2024 | |
| Spineology INC. | $126.03 | 2025 | |
| Pfizer INC. | $123.89 | 2019-2024 | |
| Medtronic, INC. | $119.19 | 2021-2025 | Strata, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $113.13 | 2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.57 | 2021 | |
| Providence Medical Technology, INC. | $98.86 | 2025 | |
| Amgen INC. | $90.53 | 2023 | Repatha |
| Abbott Laboratories | $77.93 | 2023-2024 | Aveir, Assurity |
| Axogen | $49.02 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.38 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $31.55 | 2023 | Uptravi |
| Novartis Pharmaceuticals Corporation | $30.91 | 2019 | |
| Integra Lifesciences Corporation | $25.57 | 2019 | |
| Novo Nordisk INC | $24.88 | 2020 | |
| Solventum Corporation | $22.81 | 2025 | Prevena |
| Csl Behring | $22.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.01 | 2021 | |
| Biocomposites INC | $19.35 | 2025 | Stimulan |
| Penumbra, INC. | $17.29 | 2023 | Indigo System |
| Depuy Synthes Sales INC. | $15.42 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.